Navigating Zika Testing and Diagnostics
At a Glance
Current guidelines advise against routine Zika testing for asymptomatic pregnant women to avoid false positives. If symptoms occur, doctors use PCR tests early on and antibody tests later. Cross-reactivity with viruses like Dengue can complicate antibody test results.
Navigating medical tests for Zika can be confusing. Unlike a simple blood sugar test, Zika diagnostics are a snapshot in time; the virus moves through different parts of your body at different speeds, and your immune system takes time to respond.
The Current Guidelines for Pregnant Women
If you are pregnant, you might assume you should get a blood test immediately after traveling. However, public health guidelines now recommend against routine Zika testing for pregnant women who have NO symptoms, even if they traveled to a Zika-affected area [1].
Why? Because the blood tests are prone to “false positives” and cross-reactivity with other viruses, which can cause severe psychological distress and lead to unnecessary, invasive procedures. Instead, doctors typically monitor asymptomatic pregnant women through regular, detailed ultrasounds to watch the baby’s development.
The Two Main Types of Tests (For Those with Symptoms)
If you do develop symptoms, there are two primary ways doctors look for Zika:
1. The Virus Search: NAAT (PCR)
Nucleic Acid Amplification Testing (NAAT), often called PCR, looks for the actual genetic material of the Zika virus [2][3].
- When it’s used: This is the best test during the early, acute phase of infection (usually the first 7 to 14 days after symptoms start) [2][4].
- Where it looks: Doctors typically test both your blood and your urine [5].
2. The Immune Search: IgM Serology
Once the virus is no longer detectable in your blood, doctors look for IgM antibodies, which your immune system creates to fight the infection [2][6].
- When it’s used: This test is usually most effective starting about 4 to 7 days after symptoms begin [4][2].
- The Catch: This test is “less specific.” Because Zika is closely related to other viruses like Dengue, your immune system may produce antibodies that look like Zika antibodies even if you actually have (or had) Dengue [4][7].
The Challenge of “Cross-Reactivity”
If you have ever been exposed to other flaviviruses (like Dengue, West Nile, or Yellow Fever) or have been vaccinated against them, your Zika antibody test might come back as a “false positive” [8][9]. This is called cross-reactivity.
To help clarify, doctors may use a more specialized test called a PRNT (Plaque Reduction Neutralization Test) [8][10]. While PRNT is the “gold standard,” it is not perfect. In patients who have lived in or traveled to areas where multiple flaviviruses (like Dengue) are common, PRNT often cannot definitively distinguish between Zika and Dengue antibodies [11][12]. This ambiguity is a major reason why routine testing is discouraged.
What About Amniocentesis?
For pregnant women with confirmed or highly suspected Zika, testing the amniotic fluid around the baby (amniocentesis) is sometimes considered. However, this is not routinely recommended for everyone. A positive result in the amniotic fluid confirms the virus reached the baby’s environment, but it does not perfectly predict whether the baby will develop severe complications. Discuss the risks and benefits of this invasive procedure closely with a Maternal-Fetal Medicine specialist.
Common questions in this guide
Should I get a Zika test if I am pregnant but have no symptoms?
What is the difference between a PCR and an antibody test for Zika?
Why might my Zika test show a false positive?
Do I need an amniocentesis if I test positive for Zika during pregnancy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Since I am pregnant but have no symptoms, what is our plan for monitoring via ultrasound?
- 2.Based on the date my symptoms started, should we run a PCR test or an antibody test?
- 3.Could my positive antibody test be a result of my past travel or the Dengue vaccine I received?
- 4.What are the specific risks and benefits of an amniocentesis for my situation?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
Zika Virus Infection in the Pregnant Woman.
Holtzman M, Golden WC, Sheffield JS
Clinical obstetrics and gynecology 2018; (61(1)):177-185 doi:10.1097/GRF.0000000000000343.
PMID: 29319591 - 2
Advances in Diagnostic Methods for Zika Virus Infection.
Herrada CA, Kabir MA, Altamirano R, Asghar W
Journal of medical devices 2018; (12(4)):0408021-4080211 doi:10.1115/1.4041086.
PMID: 30662580 - 3
Development of a reverse transcription quantitative polymerase chain reaction-based assay for broad coverage detection of African and Asian Zika virus lineages.
Yang Y, Wong G, Ye B, et al.
Virologica Sinica 2017; (32(3)):199-206 doi:10.1007/s12250-017-3958-y.
PMID: 28530022 - 4
Accuracy of the Zika IgM Antibody Capture Enzyme-Linked Immunosorbent Assay from the Centers for Disease Control and Prevention (CDC Zika MAC-ELISA) for Diagnosis of Zika Virus Infection.
Machado Portilho M, de Moraes L, Kikuti M, et al.
Diagnostics (Basel, Switzerland) 2020; (10(10)) doi:10.3390/diagnostics10100835.
PMID: 33080935 - 5
The Emergence of Zika Virus: A Narrative Review.
Anderson KB, Thomas SJ, Endy TP
Annals of internal medicine 2016; (165(3)):175-83 doi:10.7326/M16-0617.
PMID: 27135717 - 6
Diagnostic performance of anti-Zika virus IgM, IgAM and IgG ELISAs during co-circulation of Zika, dengue, and chikungunya viruses in Brazil and Venezuela.
Morales I, Rosenberger KD, Magalhaes T, et al.
PLoS neglected tropical diseases 2021; (15(4)):e0009336 doi:10.1371/journal.pntd.0009336.
PMID: 33872309 - 7
Seroprevalence of Zika virus in selected regions in Kenya.
Kisuya B, Masika MM, Bahizire E, Oyugi JO
Transactions of the Royal Society of Tropical Medicine and Hygiene 2019; (113(12)):735-739 doi:10.1093/trstmh/trz077.
PMID: 31639184 - 8
Zika Virus IgM Detection and Neutralizing Antibody Profiles 12-19 Months after Illness Onset.
Griffin I, Martin SW, Fischer M, et al.
Emerging infectious diseases 2019; (25(2)):299-303 doi:10.3201/eid2502.181286.
PMID: 30666931 - 9
Zika Virus: New Clinical Syndromes and Its Emergence in the Western Hemisphere.
Lazear HM, Diamond MS
Journal of virology 2016; (90(10)):4864-4875 doi:10.1128/JVI.00252-16.
PMID: 26962217 - 10
Ability To Serologically Confirm Recent Zika Virus Infection in Areas with Varying Past Incidence of Dengue Virus Infection in the United States and U.S. Territories in 2016.
Lindsey NP, Staples JE, Powell K, et al.
Journal of clinical microbiology 2018; (56(1)) doi:10.1128/JCM.01115-17.
PMID: 29093104 - 11
Development of Zika Virus Serological Testing Strategies in New York State.
Lee WT, Wong SJ, Kulas KE, et al.
Journal of clinical microbiology 2018; (56(3)) doi:10.1128/JCM.01591-17.
PMID: 29263203 - 12
A Rapid Zika Diagnostic Assay to Measure Neutralizing Antibodies in Patients.
Shan C, Xie X, Ren P, et al.
EBioMedicine 2017; (17()):157-162 doi:10.1016/j.ebiom.2017.03.006.
PMID: 28283425
This page provides educational information on Zika virus testing guidelines. It does not replace professional medical advice. Always consult your obstetrician or healthcare provider regarding testing and pregnancy monitoring.
Get notified when new evidence is published on Zika virus disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.